Literature DB >> 12369968

Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies.

C Olive1, I Toth, D Jackson.   

Abstract

Significant advances have been made in the field of peptide chemistry, especially in the design of synthetic peptide immunogens which has led to new concepts and strategies for human vaccine development. This article reviews some of these technological advances and approaches to vaccine design including the multiple antigenic peptide system, the lipid polylysine core peptide system, the polymerization of peptides into multivalent immunogens and self adjuvanting synthetic peptide-based immunogens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12369968     DOI: 10.2174/1389557013406666

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  9 in total

Review 1.  Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease.

Authors:  Michael R Batzloff; Manisha Pandey; Colleen Olive; Michael F Good
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Generating DNA sequences encoding tandem peptide repeats suitable for expression and immunological application.

Authors:  Hongwei Hou; Zhiqian Zhang; Wei Zhao; Jinyan Hou
Journal:  World J Microbiol Biotechnol       Date:  2012-02-22       Impact factor: 3.312

3.  Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

Authors:  Colleen Olive; Michael Batzloff; Aniko Horváth; Timothy Clair; Penny Yarwood; Istvan Toth; Michael F Good
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 4.  Cutting edge issues in rheumatic fever.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

5.  Multiple antigenic peptides facilitate generation of anti-prion antibodies.

Authors:  J Bainbridge; N Jones; B Walker
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

6.  Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin.

Authors:  Catarina J M Braga; Glauce M G Rittner; Julian E Muñoz Henao; Aline F Teixeira; Liliana M Massis; Maria E Sbrogio-Almeida; Carlos P Taborda; Luiz R Travassos; Luís C S Ferreira
Journal:  Infect Immun       Date:  2009-02-09       Impact factor: 3.441

Review 7.  Chlamydia trachomatis vaccine research through the years.

Authors:  Katelijn Schautteet; Evelien De Clercq; Daisy Vanrompay
Journal:  Infect Dis Obstet Gynecol       Date:  2011-06-26

8.  Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship.

Authors:  Mehfuz Zaman; Abu-Baker M Abdel-Aal; Yoshio Fujita; Karen S M Phillipps; Michael R Batzloff; Michael F Good; Istvan Toth
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

9.  A high-performance thioredoxin-based scaffold for peptide immunogen construction: proof-of-concept testing with a human papillomavirus epitope.

Authors:  Elena Canali; Angelo Bolchi; Gloria Spagnoli; Hanna Seitz; Ivonne Rubio; Thelma A Pertinhez; Martin Müller; Simone Ottonello
Journal:  Sci Rep       Date:  2014-04-22       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.